Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors

被引:24
|
作者
Dong, Jinyun [1 ,2 ,4 ]
Huang, Guang [1 ]
Cui, Qing [1 ]
Meng, Qingqing [1 ]
Li, Shaoshun [1 ]
Cui, Jiahua [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, 800 Dongchuan Rd, Shanghai, Peoples R China
[2] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, 800 Dongchuan Rd, Shanghai, Peoples R China
[4] Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
CYP1; enzymes; CYP1B1; inhibitors; alpha-Naphthoflavone derivatives; SARs; DNA ADDUCT FORMATION; DESIGN; RESISTANCE; EXPRESSION; ANALOGS;
D O I
10.1016/j.ejmech.2020.112895
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytochrome P450 1B1 (CYP1B1) has been well validated as an attractive target for cancer prevention and drug resistance reversal. In continuation of our interest in this area, herein, a set of forty-six 6,7,10-trimethoxy-alpha-naphthoflavone derivatives varying in B ring was synthesized and screened against CYP1 enzymes, leading to the identification of fluorine-containing compound 15i as the most potent and selective CYP1B1 inhibitor (IC50 value of 0.07 nM), being 84-fold more potent than that of the template molecule ANF. Alternatively, the amino-substituted derivative 13h not only possessed a potent inhibitory effect on CYP1B1 (IC50 value of 0.98 nM), but also had a substantially increased water solubility as compared with the lead ANF (311 mu g/mL for 13h and <5 mu g/mL for ANF). The current study expanded the structural diversity of CYP1B1 inhibitors, and compound 13h could be considered as a promising starting point with great potential for further studies. (c) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors
    Meredith, Erik L.
    Ksander, Gary
    Monovich, Lauren G.
    Papillon, Julien P. N.
    Liu, Qian
    Miranda, Karl
    Morris, Patrick
    Rao, Chang
    Burgis, Robin
    Capparelli, Michael
    Hu, Qi-Ying
    Singh, Alok
    Rigel, Dean F.
    Jeng, Arco Y.
    Beil, Michael
    Fu, Fumin
    Hu, Chii-Whei
    LaSala, Daniel
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (12): : 1203 - 1207
  • [42] Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors
    Zhao, Bin
    Li, Yixuan
    Xu, Pan
    Dai, Yang
    Luo, Cheng
    Sun, Yiming
    Ai, Jing
    Geng, Meiyu
    Duan, Wenhu
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (06): : 629 - 634
  • [43] Discovery of novel benzothiophene derivatives as potent and narrow spectrum inhibitors of DYRK1A and DYRK1B
    Segretti, Natanael D.
    Takarada, Jessica E.
    Ferreira, Marcos A., Jr.
    Santiago, Andre da Silva
    Teodoro, Bruno V. M.
    Damiao, Mariana C. F. C. B.
    Godoi, Paulo H.
    Cunha, Micael R.
    Fala, Angela M.
    Ramos, Priscila Z.
    Ishikawa, Eloisa E.
    Mascarello, Alessandra
    Serafim, Ricardo A. M.
    Azevedo, Hatylas
    Guimaraes, Cristiano R. W.
    Counago, Rafael M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 68
  • [44] Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors
    Lin, Jian
    Lu, Wei
    Caravella, Justin A.
    Campbell, Ann Marie
    Diebold, R. Bruce
    Ericsson, Anna
    Fritzen, Edward
    Gustafson, Gary R.
    Lancia, David R., Jr.
    Shelekhin, Tatiana
    Wang, Zhongguo
    Castro, Jennifer
    Clarke, Andrea
    Gotur, Deepali
    Josephine, Helen R.
    Katz, Marie
    Diep, Hien
    Kershaw, Mark
    Yao, Lili
    Kauffman, Goss
    Hubbs, Stephen E.
    Luke, George P.
    Toms, Angela V.
    Wang, Liann
    Bair, Kenneth W.
    Barr, Kenneth J.
    Dinsmore, Christopher
    Walker, Duncan
    Ashwell, Susan
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (14) : 6575 - 6596
  • [45] Synthesis, selective pH-sensing activity and logic behavior of highly water-soluble 1,8-naphthalimide and dihydroimidazonaphthalimide derivatives
    Georgiev, Nikolai I.
    Dimov, Stefan M.
    Asiri, Abdullah M.
    Alamry, Khalid A.
    Obaid, Abdullah Y.
    Bojinov, Vladimir B.
    JOURNAL OF LUMINESCENCE, 2014, 149 : 325 - 332
  • [46] Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity
    Ma, Zonghui
    Jiang, Ling
    Li, Bingyan
    Liang, Dailin
    Feng, Yu
    Liu, Li
    Jiang, Cheng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 46
  • [47] Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B Inhibitors
    Patel, Dipam
    Jain, Mukul
    Shah, Shailesh R.
    Bahekar, Rajesh
    Jadav, Pradip
    Darji, Brijesh
    Siriki, Yernaidu
    Bandyopadhyay, Debdutta
    Joharapurkar, Amit
    Kshirsagar, Samadhan
    Patel, Harilal
    Shaikh, Mubeen
    Sairam, Kalapatapu V. V. M.
    Patel, Pankaj
    CHEMMEDCHEM, 2011, 6 (06) : 1011 - 1016
  • [48] Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing
    Soldermann, Carole Pissot
    Simic, Oliver
    Renatus, Martin
    Erbel, Paulus
    Melkko, Samu
    Wartmann, Markus
    Bigaud, Marc
    Weiss, Andreas
    McSheehy, Paul
    Endres, Ralf
    Santos, Paulo
    Blank, Jutta
    Schuffenhauer, Ansgar
    Bold, Guido
    Buschmann, Nicole
    Zoller, Thomas
    Altmann, Eva
    Manley, Paul W.
    Dix, Ina
    Buchdunger, Elisabeth
    Scesa, Julien
    Quancard, Jean
    Schlapbach, Achim
    Bornancin, Frederic
    Radimerski, Thomas
    Regnier, Catherine H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 14576 - 14593
  • [49] Discovery of Dihydro-1,4-Benzoxazine Carboxamides as Potent and Highly Selective Inhibitors of Sirtuin-1
    Spinck, Martin
    Bischoff, Matthias
    Lampe, Philipp
    Meyer-Almes, Franz-Josef
    Sievers, Sonja
    Neumann, Heinz
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (09) : 5838 - 5849
  • [50] Discovery of Pyridine-2-Carboxamides Derivatives as Potent and Selective HPK1 Inhibitors for the Treatment of Cancer
    Peng, Jingjing
    Ding, Xiaoyu
    Chen, Celia Xiaojing
    Zhao, Pei
    Ding, Xiao
    Zhang, Man
    Aliper, Alex
    Ren, Feng
    Lu, Hongfu
    Zhavoronkov, Alex
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 21520 - 21544